Clinic
Banner Churchill Community Hospital
Banner Churchill Community Hospital was paid $7.68M by Medicaid between Jan 2018 and Dec 2024, across 201 billing codes. Its largest line is 99284, emergency room visit (serious) — 22% of everything it billed.
33Billing provider infoBANNER CHURCHILL COMMUNITY HOSPITAL
FALLON, NV 89406
FALLON, NV 89406
33aNPI1265811251assigned 05/22/2015
33bProvider typeClinic/Center
28Total paid$7.68M
24GClaims519,174
24DCodes billed201
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinic/Center providers in Nevada
Rank by total paid#5 of 62
Median peer was paid$254K
This provider vs. median30×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 77,601 | $1.32M | |
| 2019 | 97,808 | $1.27M | |
| 2020 | 58,582 | $974K | |
| 2021 | 65,856 | $896K | |
| 2022 | 71,478 | $1.13M | |
| 2023 | 79,112 | $1.16M | |
| 2024incomplete | 68,737 | $930K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 22% | 17,029 | 14,035 | $1.73M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 17% | 20,231 | 17,782 | $1.34M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 13% | 9,687 | 7,454 | $975K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 8.8% | 2,854 | 2,296 | $673K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 4.9% | 8,585 | 2,145 | $375K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.6% | 7,874 | 6,958 | $277K |
| A0425 | Ground mileage, per statute mile | 3.6% | 12,247 | 6,185 | $275K |
| A0427 | Emergency ambulance ride, advanced life supportAmbulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) | 3.4% | 4,387 | 2,667 | $258K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.8% | 2,514 | 2,063 | $213K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2.3% | 883 | 733 | $173K |
| A0429 | Emergency ambulance ride, basic life supportAmbulance service, basic life support, emergency transport (bls-emergency) | 1.6% | 2,960 | 1,772 | $125K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1.4% | 1,493 | 1,353 | $105K |
189 more codes
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1.3% | 4,633 | $98K |
| 76801 | 1.2% | 1,234 | $94K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 860 | $69K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 4,598 | $56K |
| 80053 | Comprehensive metabolic panel | <1% | 34,137 | $55K |
| A0428 | Ambulance service, basic life support, non-emergency transport, (bls) | <1% | 1,487 | $55K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 5,997 | $55K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 10,964 | $46K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 4,949 | $45K |
| 76830 | Ultrasound, transvaginal | <1% | 828 | $44K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 843 | $43K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 228 | $37K |
| 97162 | <1% | 329 | $35K | |
| A0426 | Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) | <1% | 457 | $33K |
| 80061 | Lipid panel | <1% | 10,044 | $32K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 3,440 | $27K |
| 80050 | General health panel | <1% | 644 | $25K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 859 | $24K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,677 | $22K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 75 | $19K |
| 84702 | <1% | 3,249 | $17K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 9,652 | $14K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 97 | $13K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 179 | $13K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 71 | $10K |
| 73562 | <1% | 896 | $9K | |
| 87653 | <1% | 615 | $9K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 8,277 | $9K |
| 73130 | <1% | 1,234 | $8K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 35,657 | $8K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 437 | $8K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 10,037 | $7K |
| 73610 | <1% | 1,099 | $6K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,691 | $6K |
| 73630 | <1% | 1,018 | $6K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 164 | $6K |
| G0378 | Hospital observation service, per hour | <1% | 167 | $5K |
| 87077 | <1% | 3,611 | $5K | |
| 93971 | <1% | 109 | $4K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 40 | $4K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,219 | $4K |
| 73030 | <1% | 584 | $4K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 8,766 | $4K |
| 83880 | <1% | 2,565 | $3K | |
| 86850 | <1% | 2,042 | $3K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 103 | $3K |
| 80081 | <1% | 91 | $3K | |
| 74018 | <1% | 392 | $3K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,853 | $2K |
| 72100 | <1% | 142 | $2K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 74 | $2K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,985 | $2K |
| 82950 | <1% | 411 | $2K | |
| 87186 | <1% | 3,516 | $2K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 2,066 | $2K |
| 84481 | <1% | 137 | $2K | |
| 73110 | <1% | 442 | $2K | |
| 86141 | <1% | 619 | $2K | |
| 80074 | <1% | 14 | $1K | |
| 82728 | <1% | 960 | $1K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 7,876 | $1K |
| 82607 | <1% | 2,651 | $1K | |
| 59025 | Fetal non-stress test | <1% | 23 | $1K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 913 | $1K |
| 87420 | <1% | 533 | $1K | |
| 87400 | <1% | 3,817 | $1K | |
| 86803 | <1% | 905 | $950.63 | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 19 | $863.20 |
| 85027 | <1% | 3,795 | $859.12 | |
| 87070 | <1% | 619 | $840.88 | |
| 71045 | Radiologic examination, chest; single view | <1% | 7,381 | $768.25 |
| J3490 | Unclassified drugs | <1% | 16,079 | $766.35 |
| 83655 | <1% | 120 | $764.88 | |
| 80320 | <1% | 1,756 | $757.79 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 266 | $743.44 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 4,312 | $724.92 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,019 | $692.80 |
| 83690 | <1% | 6,125 | $679.75 | |
| 82947 | <1% | 4,857 | $674.59 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 303 | $646.40 |
| 82951 | <1% | 13 | $645.77 | |
| 81025 | <1% | 4,561 | $634.91 | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 2,119 | $585.95 |
| 86038 | <1% | 235 | $555.68 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,356 | $520.54 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 12,221 | $514.50 |
| 87040 | <1% | 3,598 | $476.51 | |
| 73502 | <1% | 71 | $450.54 | |
| 84484 | <1% | 7,628 | $441.61 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 8,422 | $437.86 |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 26 | $411.16 |
| 85610 | <1% | 4,277 | $408.06 | |
| J8597 | Antiemetic drug, oral, not otherwise specified | <1% | 2,225 | $388.16 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,485 | $380.55 |
| 81001 | <1% | 12,106 | $374.99 | |
| 85730 | <1% | 845 | $371.67 | |
| 12001 | <1% | 17 | $371.03 | |
| 85652 | <1% | 1,840 | $325.18 | |
| 96376 | <1% | 1,176 | $280.83 | |
| 87340 | <1% | 1,480 | $240.47 | |
| 87522 | Neg quan hep c or qual rna | <1% | 14 | $239.95 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 271 | $225.29 |
| 90715 | <1% | 264 | $210.29 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 3,295 | $187.60 |
| 84466 | <1% | 748 | $186.86 | |
| 83605 | <1% | 3,638 | $185.61 | |
| 74021 | <1% | 126 | $182.97 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,452 | $167.26 |
| 82043 | <1% | 1,126 | $165.05 | |
| 84403 | <1% | 78 | $161.47 | |
| 81003 | <1% | 5,117 | $158.28 | |
| 86787 | <1% | 298 | $154.96 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 8,639 | $149.81 |
| 86140 | <1% | 973 | $148.10 | |
| 84156 | <1% | 79 | $131.28 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 8,263 | $127.44 |
| 84153 | <1% | 112 | $125.38 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 12,325 | $114.81 |
| 86762 | <1% | 919 | $113.50 | |
| 85210 | <1% | 18 | $112.96 | |
| 83540 | <1% | 1,247 | $111.49 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 3,003 | $94.50 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 1,096 | $88.03 |
| 85055 | <1% | 25 | $81.01 | |
| 84100 | <1% | 115 | $79.89 | |
| 86900 | <1% | 2,188 | $76.66 | |
| 83735 | <1% | 2,696 | $76.26 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 350 | $75.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 2,526 | $70.63 |
| 84439 | <1% | 4,117 | $69.16 | |
| 84703 | <1% | 414 | $69.16 | |
| 82270 | <1% | 143 | $57.03 | |
| 73080 | <1% | 14 | $53.70 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 3,145 | $53.07 |
| 73090 | <1% | 15 | $51.14 | |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 1,728 | $42.46 |
| 85379 | <1% | 318 | $37.83 | |
| 87210 | <1% | 40 | $37.58 | |
| 86592 | <1% | 2,244 | $34.45 | |
| J2704 | Injection, propofol, 10 mg | <1% | 2,869 | $34.21 |
| 73140 | <1% | 14 | $28.36 | |
| 96367 | <1% | 32 | $26.69 | |
| 80076 | <1% | 27 | $25.33 | |
| A9270 | Non-covered item or service | <1% | 8,371 | $23.22 |
| 86901 | <1% | 2,468 | $22.44 | |
| 84550 | <1% | 283 | $12.32 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 2,817 | $12.03 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | <1% | 19 | $11.90 |
| 82105 | <1% | 44 | $11.42 | |
| 86780 | <1% | 394 | $9.03 | |
| 82550 | <1% | 130 | $8.88 | |
| 87205 | <1% | 250 | $8.73 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 936 | $8.37 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 730 | $8.12 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 346 | $3.54 |
| 82565 | <1% | 14 | $3.50 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 288 | $2.42 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,505 | $2.31 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 702 | $1.70 |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 108 | $1.07 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 36 | $0.65 |
| J7999 | Compounded drug, not otherwise classified | <1% | 145 | $0.53 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 50 | $0.05 |
| 85007 | 0% | 104 | $0.00 | |
| S0028 | Injection, famotidine, 20 mg | 0% | 16 | $0.00 |
| 82570 | 0% | 102 | $0.00 | |
| 87631 | 0% | 1,970 | $0.00 | |
| 83718 | 0% | 68 | $0.00 | |
| 82465 | 0% | 70 | $0.00 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 0% | 78 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 474 | $0.00 |
| 86431 | 0% | 30 | $0.00 | |
| 83525 | 0% | 45 | $0.00 | |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 79 | $0.00 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 0% | 83 | $0.00 |
| J3370 | Injection, vancomycin hcl, 500 mg | 0% | 13 | $0.00 |
| 94664 | 0% | 100 | $0.00 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 22 | $0.00 |
| 86200 | 0% | 13 | $0.00 | |
| 86336 | 0% | 13 | $0.00 | |
| 82746 | 0% | 175 | $0.00 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 297 | $0.00 |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | 0% | 64 | $0.00 |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 0% | 15 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 89 | $0.00 |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 0% | 34 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 36 | $0.00 |
| 82677 | 0% | 13 | $0.00 | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 0% | 36 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCARNAHAN, ROBERT (CEO)
Parent organizationBANNER HEALTH
| Provider | Location | Paid |
|---|---|---|
| Banner Churchill Community Hospital | Fallon, NV | $13.22M |
| Banner Churchill Community Hospital | Fernley, NV | $3.79M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.